ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

NCI CTEP Approved Trials For the Month of December

December 27, 2013

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003